Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Fulcrum Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 105 | 110 | +5 |
| Shares | 52.2M | 50.6M | −1.55M (−3.0%) |
| Value | $422.1M | $368.5M | −$53.6M (−12.7%) |
New holders (22)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nantahala Capital Management, LLC | 500,000 | $3.64M | 0.33% |
| Norges Bank | 356,600 | $2.60M | 0.00% |
| Two Sigma Investments, LP | 133,019 | $968.4K | 0.00% |
| Tekla Capital Management LLC | 58,537 | $426.1K | 0.02% |
| PDT Partners, LLC | 41,403 | $301.4K | 0.05% |
| Alps Advisors Inc | 35,358 | $257.4K | 0.00% |
| Cornercap Investment Counsel Inc | 34,886 | $254.0K | 0.04% |
| XTX Topco Ltd | 34,882 | $253.9K | 0.05% |
| Graham Capital Management, L.P. | 21,353 | $155.4K | 0.01% |
| Blackstone Group Inc. | 19,216 | $139.9K | 0.00% |
| Old Well Partners, LLC | 17,300 | $125.9K | 0.11% |
| Alpine Global Management, LLC | 16,073 | $117.0K | 0.04% |
| Principal Financial Group Inc | 12,821 | $93.3K | 0.00% |
| Jane Street Group, LLC | 11,687 | $85.1K | 0.00% |
| Corton Capital Inc. | 11,565 | $84.2K | 0.07% |
| Landscape Capital Management, L.L.C. | 11,114 | $80.9K | 0.01% |
| Delphia (USA) Inc. | 10,625 | $77.3K | 0.09% |
| UBS Group AG | 3,789 | $27.6K | 0.00% |
| SVB Financial Group | 22,422 | $22.4K | 0.06% |
| SOA Wealth Advisors, LLC. | 800 | $5.82K | 0.00% |
| Parallel Advisors, LLC | 77 | $561 | 0.00% |
| NewSquare Capital LLC | 30 | $218 | 0.00% |
Sold out (17)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,494,003 | $12.1M |
| Perceptive Advisors LLC | 294,118 | $2.38M |
| Monashee Investment Management LLC | 200,000 | $1.62M |
| HRT Financial LP | 20,857 | $168.0K |
| Gsa Capital Partners LLP | 17,879 | $145.0K |
| Healthcare of Ontario Pension Plan Trust Fund | 17,000 | $138.0K |
| Ensign Peak Advisors, Inc | 15,610 | $126.0K |
| Trexquant Investment LP | 13,886 | $112.0K |
| Dynamic Technology Lab Private Ltd | 11,652 | $94.0K |
| Susquehanna International Group, LLP | 10,006 | $81.0K |
| BNP Paribas Arbitrage, SA | 9,551 | $77.3K |
| Allspring Global Investments Holdings, LLC | 9,176 | $74.0K |
| Sandia Investment Management LP | 5,000 | $40.0K |
| Group One Trading, L.P. | 880 | $7.00K |
| Quadrant Capital Group LLC | 258 | $2.00K |
| Lindbrook Capital, LLC | 277 | $2.00K |
| Allworth Financial LP | 65 | $1.00K |